ENTITY
Jiangsu Hengrui Medicine

Jiangsu Hengrui Medicine (600276 CH)

402
Analysis
Health Care • China
Jiangsu Hengrui Medicine Co., Ltd. develops, manufactures, and markets a variety of medicines and medicine packing materials. The Company's products include anti-tumor medicines, pain-killers, anti-infection medicines, aluminum foil, and other related products.
more
bullish•Cross Asset Strategy
•26 Apr 2020 05:09

China A-Share Strategy: What Are Mutual Funds Buying in 1Q? Tech and Pharma

Chinese fund managers have added more tech and pharma stocks than any other sectors in their portfolios in 1Q this year, according to the fund...

Logo
Roger Xie
406 Views
Share
bearish•Quantitative Analysis
•23 Mar 2020 14:52

SH/SZ Connect Flows: Hikvision, Mindray, Moutai, Hengrui

In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...

Logo
410 Views
Share
bullish•Quantitative Analysis
•17 Dec 2019 17:32

Shanghai/​​​Shenzhen Connect Flows: $3bn Inflows Ahead of Phase 1 Trade Deal

In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...

Logo
504 Views
Share
bullish•MSCI ACWI Index
•22 Nov 2019 05:57

Global Equity Strategy: Health Care Hitting On All Cylinders - Overweight

Global equities remain in a short-term consolidation phase, however we continue to believe the longer-term trend is up and to the right for the...

Logo
453 Views
Share
bullish•Kweichow Moutai
•16 Sep 2019 11:38

Shanghai/​​Shenzhen Connect Ideas: Pre-Mid Autumn Hard Liquor Outflows (2019-09-13)

In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...

Logo
450 Views
Share
x